Neogen (NEOG) Cash & Equivalents Growth (3y) (2013 - 2026)
Neogen (NEOG) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -13.31% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 34.27% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 8.16% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 40.74% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -2.57% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.72% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 38.28% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 32.23% |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | 4.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 4.35% |
| Feb 28, 2026 | 33.55% |
| Nov 30, 2025 | 13.27% |
| Aug 31, 2025 | 9.05% |
| May 31, 2025 | 42.61% |
| Feb 28, 2025 | 43.88% |
| Nov 30, 2024 | 39.99% |
| Aug 31, 2024 | 19.12% |
| May 31, 2024 | 31.17% |
| Feb 29, 2024 | 30.00% |
| Nov 30, 2023 | 21.80% |
| Aug 31, 2023 | 43.16% |
| May 31, 2023 | 35.05% |
| Feb 28, 2023 | 9.76% |
| Nov 30, 2022 | 14.62% |
| Aug 31, 2022 | 23.91% |
| May 31, 2022 | 2.18% |
| Feb 28, 2022 | -22.90% |
| Nov 30, 2021 | -20.46% |
| Aug 31, 2021 | -9.83% |